Literature DB >> 8668347

Mos proto-oncogene function during oocyte maturation in Xenopus.

L M Roy1, O Haccard, T Izumi, B G Lattes, A L Lewellyn, J L Maller.   

Abstract

The function of the Xenopus c-mos proto-oncogene product (Mos(xe)) has been investigated during oocyte maturation. Experiments with a new antibody able to immunoblot Mos(xe) demonstrated the time course of MAP kinase (MAP K) activation in oocytes paralleled Mos(xe) accumulation, and in activated eggs the deactivation of MAP K paralleled the degradation of Mos(xe). Ablation of Mos synthesis by microinjection of antisense oligodeoxynucleotides abolished activation of MAP K by progesterone, but microinjection of GST-Mos fully restored both MAP K activation and germinal vesicle breakdown (GVBD). The Mos(xe) level at metaphase of Meiosis I (MI) was 2 - 3-fold less than that at metaphase of Meiosis II (MII), but MAP K activation was maximal at metaphase in both MI and MII. In the transition between MI and MII, both cyclin B and Mos(xe) levels rapidly declined in the presence of cycloheximide and injection of exogenous GST-Mos(xe) did not prevent degradation of either protein, although MAP K was activated. Microinjection of GST-Mos(xe) into oocytes was able to activate MAP K before GVBD and H1 kinase activation, and microinjection of constitutively-activated thiophosphorylated MAP K induced de novo synthesis of Mos(xe) before H1 kinase activation, suggesting the existence of a positive feedback loop between MAP K and Mos(xe) accumulation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8668347

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  28 in total

1.  Distinct, constitutively active MAPK phosphatases function in Xenopus oocytes: implications for p42 MAPK regulation In vivo.

Authors:  M L Sohaskey; J E Ferrell
Journal:  Mol Biol Cell       Date:  1999-11       Impact factor: 4.138

2.  A novel regulatory element determines the timing of Mos mRNA translation during Xenopus oocyte maturation.

Authors:  Amanda Charlesworth; John A Ridge; Leslie A King; Melanie C MacNicol; Angus M MacNicol
Journal:  EMBO J       Date:  2002-06-03       Impact factor: 11.598

3.  Detection of multistability, bifurcations, and hysteresis in a large class of biological positive-feedback systems.

Authors:  David Angeli; James E Ferrell; Eduardo D Sontag
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-06       Impact factor: 11.205

4.  Mechanistic studies of the mitotic activation of Mos.

Authors:  Jianbo Yue; James E Ferrell
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

5.  DAF-2 and ERK couple nutrient availability to meiotic progression during Caenorhabditis elegans oogenesis.

Authors:  Andrew L Lopez; Jessica Chen; Hyoe-Jin Joo; Melanie Drake; Miri Shidate; Cedric Kseib; Swathi Arur
Journal:  Dev Cell       Date:  2013-10-10       Impact factor: 12.270

6.  The beta subunit of CKII negatively regulates Xenopus oocyte maturation.

Authors:  M Chen; J A Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

7.  Hsp90 is required for c-Mos activation and biphasic MAP kinase activation in Xenopus oocytes.

Authors:  D L Fisher; E Mandart; M Dorée
Journal:  EMBO J       Date:  2000-04-03       Impact factor: 11.598

8.  Ringo/cyclin-dependent kinase and mitogen-activated protein kinase signaling pathways regulate the activity of the cell fate determinant Musashi to promote cell cycle re-entry in Xenopus oocytes.

Authors:  Karthik Arumugam; Melanie C MacNicol; Yiying Wang; Chad E Cragle; Alan J Tackett; Linda L Hardy; Angus M MacNicol
Journal:  J Biol Chem       Date:  2012-01-03       Impact factor: 5.157

9.  Activation of p90 Rsk1 is sufficient for differentiation of PC12 cells.

Authors:  Eran Silverman; Morten Frödin; Steen Gammeltoft; James L Maller
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

10.  Mos is not required for the initiation of meiotic maturation in Xenopus oocytes.

Authors:  Aude Dupré; Catherine Jessus; René Ozon; Olivier Haccard
Journal:  EMBO J       Date:  2002-08-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.